Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study

OBJECTIVE: To quantify the effect on cervical disease at age 20 years of immunisation with bivalent human papillomavirus (HPV) vaccine at age 12-13 years. DESIGN: Retrospective population study, 1988-96. SETTING: National vaccination and cervical screening programmes in Scotland. PARTICIPANTS: 138 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmer, Tim, Wallace, Lynn, Pollock, Kevin G, Cuschieri, Kate, Robertson, Chris, Kavanagh, Kim, Cruickshank, Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446188/
https://www.ncbi.nlm.nih.gov/pubmed/30944092
http://dx.doi.org/10.1136/bmj.l1161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446188/
https://www.ncbi.nlm.nih.gov/pubmed/30944092
http://dx.doi.org/10.1136/bmj.l1161

Ejemplares similares